Summary results of survey research of CPEM use in poker players; preliminary results presented at the College of Psychiatric and Neurologic Pharmacists 2010 Annual Meeting.
100% Renewable Energy by 2050: Fact or FantasyJohn Farrell
Can the U.S. have a 100% renewable energy economy by 2050? This short presentation by ILSR's Director of Democratic Energy John Farrell summarizes Stanford professor Mark Jacobson's landmark study of the possibility, annotated by David Roberts at Vox.
The answer? It is possible, but only with an unprecedented coordination of local, state, and federal government to lay the groundwork.
Energy generated by using wind, tides, solar, geothermal heat, and biomass including farm and animal waste is known as non-conventional energy. All these sources are renewable or inexhaustible and do not cause environmental pollution. More over they do not require heavy expenditure.
Natural resources that can be replaced and reused by nature are termed renewable. Natural resources that cannot be replaced are termed nonrenewable.
Renewable resources are replaced through natural processes at a rate that is equal to or greater than the rate at which they are used, and depletion is usually not a worry.
Nonrenewable resources are exhaustible and are extracted faster than the rate at which they formed. E.g. Fossil Fuels (coal, oil, natural gas).
The future can be great for our community, for our province, for the energy industry, for you and me and our children. However, it will require us to embrace positive change and to start the transition now. We can create an Alberta that is a renewable energy powerhouse by energy companies utilizing land and infrastructure they already use to generate renewable energy as well as using fuel cell technology to produce much cleaner energy from hydrocarbons during the transition period. And we can become the supplier of choice for clean and green hydrocarbon products, with extraction, processing and use of final products without emissions, pollution, fresh water and use of harmful chemicals. Why won't we start now? We can do it together!
100% Renewable Energy by 2050: Fact or FantasyJohn Farrell
Can the U.S. have a 100% renewable energy economy by 2050? This short presentation by ILSR's Director of Democratic Energy John Farrell summarizes Stanford professor Mark Jacobson's landmark study of the possibility, annotated by David Roberts at Vox.
The answer? It is possible, but only with an unprecedented coordination of local, state, and federal government to lay the groundwork.
Energy generated by using wind, tides, solar, geothermal heat, and biomass including farm and animal waste is known as non-conventional energy. All these sources are renewable or inexhaustible and do not cause environmental pollution. More over they do not require heavy expenditure.
Natural resources that can be replaced and reused by nature are termed renewable. Natural resources that cannot be replaced are termed nonrenewable.
Renewable resources are replaced through natural processes at a rate that is equal to or greater than the rate at which they are used, and depletion is usually not a worry.
Nonrenewable resources are exhaustible and are extracted faster than the rate at which they formed. E.g. Fossil Fuels (coal, oil, natural gas).
The future can be great for our community, for our province, for the energy industry, for you and me and our children. However, it will require us to embrace positive change and to start the transition now. We can create an Alberta that is a renewable energy powerhouse by energy companies utilizing land and infrastructure they already use to generate renewable energy as well as using fuel cell technology to produce much cleaner energy from hydrocarbons during the transition period. And we can become the supplier of choice for clean and green hydrocarbon products, with extraction, processing and use of final products without emissions, pollution, fresh water and use of harmful chemicals. Why won't we start now? We can do it together!
20180202 3 j. lombard genomind milan relazione part 2 to pub.pptxRoberto Scarafia
https://www.linkedin.com/pulse/simposio-toma-implementazione-della-farmacogenetica-nel-scarafia/
https://www.linkedin.com/pulse/malattie-psichiatriche-e-neurologiche-arriva-toma-il-test-scarafia/
2 febbraio 2018, Sala Congressi Laboratorio TOMA
Relatori: Dr. J. Lombard, Dr.ssa F.R. Grati, Dr.ssa S. De Toffol
BREVE PREMESSA
La farmacogenetica studia l’influenza dei fattori genetici sull’attività di un farmaco, la sua assimilazione e il suo metabolismo allo scopo di massimizzarne l’efficacia terapeutica e minimizzare gli effetti avversi. I fattori genetici possono giustificare fino al 95% della variabilità interpersonale nella risposta e nelle reazioni avverse a determinati trattamenti farmacologici. Finora la diagnosi ed il trattamento farmacologico in psichiatria si sono basati principalmente sul un protocollo ‘trial and error’ tramite colloquio, osservazione clinica e analisi di laboratorio costituivano esclusivamente un complemento per valutare possibili effetti collaterali o i livelli plasmatici di alcuni farmaci. L’introduzione di test di farmacogenetica consente di fornire al clinico informazioni costitutive dell’individuo relativamente al metabolismo di molti farmaci e la potenziale risposta in determinati contesti clinici al fine di ridurre i tempi ottenimento del trattamento efficace personalizzato e arricchire con le più recenti informazioni genetiche la gestione terapeutica dei pazienti.
OBIETTIVI FORMATIVI
Introdurre i principi scientifici alla base del test genetico che si presenterà durante il corso, il significato, la funzione e la rilevanza clinica per la salute mentale di ciascun gene indagato dal test;
L’utilità clinica del test Genecept: presentare come vengono riportati i risultati del test e come meglio interpretarli;
Presentare alcuni casi clinici reali per discutere circa l’utilità di un trattamento farmacologico guidato dai risultati del test genetico rispetto all’approccio tradizionale ‘trial and error’
Personalized medicine involves the prescription of specific therapeutics best suited for an individual based on their genetic or proteomic profile. This talk discusses current approaches in drug discovery/development, the role of genetics in drug metabolism, and lawful/ethical issues surrounding the deployment of new health technology. I highlight some bioinformatic roles in the drug discovery process, and discuss the use of semantic web technologies for data integration and knowledge discovery..
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Roger Chou, MD, Associate Professor of Medicine for Oregon Health & Science University
and Director of Pacific Northwest Evidence-based Practice Center.
The slides from the keynote given by Dr. Dan Malone RPh, PhD at the First International Drug-Drug Interaction Knowledge Representation Workshop on October 6th 2014 (http://icbo14.com/sessions/drug-drug-interaction-knowledge-representation-workshop/). Posted with his permission.
in this presentation about the dope testing for athletics who do doping and play game and win because of doping and sport physiotherapist who know about the methods and rule and regulation as well penalty for doping and precaution also
Drug abuse has now become a major public health problem in Nigeria requiring urgent attention. Although drug abuse cut across all age groups, the youths are however the most affected. This study aimed at assessing Community Pharmacists involvement in the rehabilitation of drug abuse victims. The study was carried out in Abuja Municipal Area Council, questionnaires were administered to Community Pharmacists practicing within the Area Council. A total of 176 Community Pharmacists participated in the study, and slightly above a quarter (27.43%) of them had post-graduate degrees. More than three-quarters (79.5%) of the study participants had received training on drug abuse. A total of 89.2% of the study participants had come across persons suspected to be abusing prescription medicines. Almost all (96.6%) of the study participants indicated that they are willing to advise persons suspected to be abusing drugs on the dangers of drug abuse, and 88.1% of the study participants had spoken to clients concerning abuse of prescription medicines. Also, more than three-quarters (80.1%) of the study participants indicated that pharmacists’ role in the prevention of drug abuse is very important. The study has revealed that Community Pharmacists can play an invaluable role in the rehabilitation of drug abuse victims in Nigeria.
20180202 3 j. lombard genomind milan relazione part 2 to pub.pptxRoberto Scarafia
https://www.linkedin.com/pulse/simposio-toma-implementazione-della-farmacogenetica-nel-scarafia/
https://www.linkedin.com/pulse/malattie-psichiatriche-e-neurologiche-arriva-toma-il-test-scarafia/
2 febbraio 2018, Sala Congressi Laboratorio TOMA
Relatori: Dr. J. Lombard, Dr.ssa F.R. Grati, Dr.ssa S. De Toffol
BREVE PREMESSA
La farmacogenetica studia l’influenza dei fattori genetici sull’attività di un farmaco, la sua assimilazione e il suo metabolismo allo scopo di massimizzarne l’efficacia terapeutica e minimizzare gli effetti avversi. I fattori genetici possono giustificare fino al 95% della variabilità interpersonale nella risposta e nelle reazioni avverse a determinati trattamenti farmacologici. Finora la diagnosi ed il trattamento farmacologico in psichiatria si sono basati principalmente sul un protocollo ‘trial and error’ tramite colloquio, osservazione clinica e analisi di laboratorio costituivano esclusivamente un complemento per valutare possibili effetti collaterali o i livelli plasmatici di alcuni farmaci. L’introduzione di test di farmacogenetica consente di fornire al clinico informazioni costitutive dell’individuo relativamente al metabolismo di molti farmaci e la potenziale risposta in determinati contesti clinici al fine di ridurre i tempi ottenimento del trattamento efficace personalizzato e arricchire con le più recenti informazioni genetiche la gestione terapeutica dei pazienti.
OBIETTIVI FORMATIVI
Introdurre i principi scientifici alla base del test genetico che si presenterà durante il corso, il significato, la funzione e la rilevanza clinica per la salute mentale di ciascun gene indagato dal test;
L’utilità clinica del test Genecept: presentare come vengono riportati i risultati del test e come meglio interpretarli;
Presentare alcuni casi clinici reali per discutere circa l’utilità di un trattamento farmacologico guidato dai risultati del test genetico rispetto all’approccio tradizionale ‘trial and error’
Personalized medicine involves the prescription of specific therapeutics best suited for an individual based on their genetic or proteomic profile. This talk discusses current approaches in drug discovery/development, the role of genetics in drug metabolism, and lawful/ethical issues surrounding the deployment of new health technology. I highlight some bioinformatic roles in the drug discovery process, and discuss the use of semantic web technologies for data integration and knowledge discovery..
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Roger Chou, MD, Associate Professor of Medicine for Oregon Health & Science University
and Director of Pacific Northwest Evidence-based Practice Center.
The slides from the keynote given by Dr. Dan Malone RPh, PhD at the First International Drug-Drug Interaction Knowledge Representation Workshop on October 6th 2014 (http://icbo14.com/sessions/drug-drug-interaction-knowledge-representation-workshop/). Posted with his permission.
in this presentation about the dope testing for athletics who do doping and play game and win because of doping and sport physiotherapist who know about the methods and rule and regulation as well penalty for doping and precaution also
Drug abuse has now become a major public health problem in Nigeria requiring urgent attention. Although drug abuse cut across all age groups, the youths are however the most affected. This study aimed at assessing Community Pharmacists involvement in the rehabilitation of drug abuse victims. The study was carried out in Abuja Municipal Area Council, questionnaires were administered to Community Pharmacists practicing within the Area Council. A total of 176 Community Pharmacists participated in the study, and slightly above a quarter (27.43%) of them had post-graduate degrees. More than three-quarters (79.5%) of the study participants had received training on drug abuse. A total of 89.2% of the study participants had come across persons suspected to be abusing prescription medicines. Almost all (96.6%) of the study participants indicated that they are willing to advise persons suspected to be abusing drugs on the dangers of drug abuse, and 88.1% of the study participants had spoken to clients concerning abuse of prescription medicines. Also, more than three-quarters (80.1%) of the study participants indicated that pharmacists’ role in the prevention of drug abuse is very important. The study has revealed that Community Pharmacists can play an invaluable role in the rehabilitation of drug abuse victims in Nigeria.
This slide deck is comprised of lectures delivered at Nova Southeastern University Colleges of Medicine (MI) and Pharmacy (PHA) in the following courses:
MI 6410 Consumer Health Informatics and Web 2.0 in Healthcare
PHA 5203 Consumer Health Informatics and Web 2.0 in Healthcare
The Science Behind Engaging Students in ClassKevin Clauson
This is the expanded version of 'How to Fight Lecturalgia'. The enhancements from the peer-reviewed literature and science behind aspects of visual design were added in response to feedback after presenting the former version. This was presented as the keynote of Faculty Development at the University of Louisiana - Monroe.
Superiority, Equivalence, and Non-Inferiority Trial DesignsKevin Clauson
http://bit.ly/bQKcGz This lecture was presented as part of the Drug Literature Evaluation course at Nova Southeastern University. Guided notes and an audience response system were used to augment to lecture. Context for my decision to share these slides can be found at the provided link.
To tweet or not to tweet: Exploring the role of social media in public health...Kevin Clauson
This is Part II (wikis & virtual worlds) of a two-part presentation on social media and public health given at the Pan American Health Organization (PAHO) in Washington, DC in November 2009
How Facebook and Twitter are Changing HealthcareKevin Clauson
Nova Southeastern University College of Pharmacy 2009 Fall Classic presentation examining the role of Facebook and Twitter in pharmacy and the development of participatory medicine.
Ethics 2.0: Implications of Connected HealthKevin Clauson
An interactive panel chaired by Dr. Joan Dzenowagis on Ethics 2.0 that utilized an audience response system at Medicine 2.0 in 2009 at Toronto, Canada.
Web 2.0-mediated Blended Learning: Separating Fact from FictionKevin Clauson
Podium presentation at Medicine 2.0 in Toronto (2009) of survey research to characterize the knowledge, familiarity, and preferences regarding Web 2.0 tools among students in pharmacy school
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
4. Emerging area of
neurocognitive enhancement in
cosmetic psychopharmacology
Neurology 2004;63(6):968-74.
Perspect Biol Med 2006;49(4):515-23.
5. Camb Q Healthc Ethics 2007;16(2):129-37.
Increasing interest in drugs for enhancing
brain function parallels evolution of
plastic surgery after World War I
6. Poll in Nature revealed one in five
(self-identified) scientists reported
having used neuroenhancers
Nature 2008;453(7195):674-5.
7. Neuroenhancer use
by students has been
studied for exam
preparation and in
classroom situations
Nat Rev Neurosci 2004;5(5):421-5.
8. The use of performance enhancing agents
has also been studied in professions
ranging from pilots to classical
musicians…and even in nervous public
speakers
Neurology 2002;59(1):123-5.
Psychopharmacologia 2000;150(3):272-82.
10. Objective
To characterize use of and perceptions
about cognitive (e.g., methylphenidate,
modafinil) and performance enhancing
(e.g., propranolol) medications, dietary
supplements (e.g., guarana), and other
substances to improve performance
in poker
11. This study did NOT examine
the use of steroids, HGH, etc.
13. Survey development
A survey tool consisting of 38 questions
was created in order to:
1) assess the use of cognitive and
performance enhancing medications
(CPEMs), dietary supplements, and
other substances by respondents to
improve their performance at poker
2) explore methods of acquisition and
motivations for poker players to use or
avoid using CPEMs
3) characterize perceptions of poker
players regarding CPEMs
16. Pilot yielded suggestions by poker players to
add products they use as CPEMs but are
not widely seen in other studies including
alcohol, hydrocodone, and marijuana
17. After pilot
and revision,
adult study
participants were
recruited via
invitations
posted on
Internet poker
forums
19. Survey flow was accelerated by skip logic
and piping which reduced the total survey
question burden for each participant
20. Reminder posts
were used during
survey administration
and to announce
closure on forums
Dillman 2009
21. Statistical analysis
Descriptive statistics (e.g., frequency
counts, standard deviation) were used
to characterize results
Logistic regression analyses and
Pearson‟s correlation coefficient were
used to determine CPEM predictors
SPSS version 16
23. Survey response
Of the submissions received,
198 poker players fully
completed the online survey
Data are reported on an item-
level basis and rounded
24. Most poker players were from
USA (59%), EU (24%),
and Canada (11%)
96% of responders were male
with an average age of 26
25. Which best describes your poker playing STATUS?
o Professional (i.e., poker is your main source of income)
o Semi-professional (i.e., poker represents a substantial
source of income)
o Amateur (i.e., poker is a hobby, but you study and prepare
to compete)
o Recreational (i.e., poker is a leisure activity that
represents a way to have a good time)
26. Respondents self-identified
poker playing status included
amateur (37%), semi-
professional (35%), professional
(25%), and recreational (3%)
No-limit hold’ em was the most
commonly played form (68%)
28. 28% of those surveyed took at
least one prescription
medication to improve poker
performance
29. Use of CPEMs to improve
performance in poker
Primary purpose was to
focus/concentrate (73%), calm
nerves (11%), stay awake (11%),
improve memory (2%),
or other (3%)
30. Which medications have you taken to improve your
performance in poker? [Please select all that apply; hold
down the Ctrl button and click to choose multiple answers]
None
Amphetamine/Dextroamphetamine (Adderal, Dexedrine, Dextrostat)
Armodafanil (Nuvigil)
Atomoxetine (Straterra)
Benzodiazepines (Valium, Xanax, Ativan, Klonopin, Restoril, etc.)
Other (if applicable)
33. Methods used by poker players to
obtain prescription medications
Via a physician 38%
Given to by players 26%
Purchased from players 26%
Purchased online 10%
34. 80% of poker players took
some type of „other substance‟
to improve performance
35. What other substance(s) have you taken to improve your
performance in poker? [Please select all that apply; hold
down the Ctrl button and click to choose multiple answers]
None
Alcohol (beer, wine, liquor)
Caffeine
Cocaine
Crystal Meth
Other (if applicable)
36. Other substance Use (%)
(N=158)
Caffeine 71
Energy drinks 51
Marijuana 34
Alcohol 30
Nicotine 29
Sports drinks 25
Cocaine 8
37. 46% took a dietary supplement to
improve their poker performance
38. Which dietary supplements have you taken to improve your
performance in poker? [Please select all that apply; hold
down the Ctrl button and click to choose multiple answers]
None
Bitter orange
Ephedra
Ginkgo biloba
Guarana
Other (if applicable)
41. Survey comments: marijuana
Many poker players (n=96)
chose to write comments in
the optional text box at the
end of the survey
A quarter of all comments
written involved marijuana
42. Marijuana comment examples
“Marijuana is by far the most safe and effective
substance used to aid in poker performance,
though amphetamines such as adderal are
among the top as well insofar as it is among
the most widely used and most effective.”
“I am a tilt monkey, then I smoke weed. I then
stop being a tilt monkey.”
“I know many people who claim they play better
on Marijuana but I don't believe it.”
43. Most common influence for WHY players
started taking medications to improve
poker performance was…
…previous use to improve performance
in a non-poker related area (e.g., studying
for exam, staying awake for a long drive)
44. Predictors for use of CPEMs*
Negative Positive
Live poker Residence in
(p=0.045) USA (p=0.003)
Previous
CPEM use
r=0.548
(p<0.001)
*Values statistically
significant at p<0.05
45. Alcohol consumption
for any purpose in this
population was 86%
Players reported
drinking an average
of 9 days/month with
5 drinks consumed on
drinking days
47. Unmonitored use of
CPEMs and methods of
acquisition highlight
safety concerns in this
cohort of poker players
48. Consequences of use can include
addiction, psychosis, and sudden death
(with structural cardiac abnormalities)*
*These are the most extreme safety issues seen with CPEMs
49. Reproduction
of an original
(counterfeit)
drug is more
likely to be
bought online
European Alliance for Access to Safe Medicines
50. Recent American Academy of
Neurology (AAN) Ethics, Law,
and Humanities Committee
guidance now states
off-label prescribing for
neuroenhancement is legally
and ethically permissible
Neurology 2009;73(17):1406-12.
51. Impact of AAN guidance
Could help the majority of
poker players who are not
currently getting their CPEMs
from a physician or
benefitting from monitoring
by a pharmacist
52. British Medical Association
“…universal access to
enhancing interventions
would bring up the base-line
level of cognitive ability,
which is generally seen to be
a good thing”
Ethical aspects of cognitive enhancement. BMA 2007.
53. CPEM users in this study
typically had tried them for
reasons other than poker prior to
using them to improve poker
performance
Up to 16% of college students
have tried psychostimulant
study aids
J Am Coll Health 2006;54(5):261-8.
57. Results of this study may not reflect
the use of CPEMs by the 50
million US and 100 million worldwide
casual poker players
.
Players who participated in this
survey may be a more serious
segment of the poker playing
population
58. However this segment also includes
those least risk averse and most
susceptible to issues with CPEMs
60. Use of CPEMs
was relatively
proliferate with
over a quarter of
players using
prescription
medications and
most using some
agent to improve
performance
61. Future considerations
Additional research and
possibly educational
initiatives are merited
based on the frequency of
CPEM use in this subset of
poker players
62. Initial results presented via poster at the
College of Psychiatric & Neurologic
Pharmacists 2010 Annual Meeting
http://cpnp.org/ed/meeting/2010